MeSH D006373 - helminthiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alembic Pharmaceuticals | Albendazole | Albendazole | 2024-09-04 | |||
| Allergan | Albendazole | Albendazole | 2019-05-20 | |||
| Bayer | Praziquantel | Biltricide | 1982-12-29 | |||
| Chartwell Pharmaceuticals | Albendazole | Albendazole | 2020-06-10 | |||
| Cipla | Albendazole | Albendazole | 2018-09-21 | |||
| Dr Reddys Laboratories | Albendazole | Albendazole | 2021-01-26 | |||
| Edenbridge Pharmaceuticals | Albendazole | Albendazole | 2019-05-14 | |||
| Endo | Praziquantel | Praziquantel | 2017-11-27 | |||
| Impax Laboratories | Albendazole | Albenza | 1996-06-11 | |||
| Mebendazole | Emverm | 1995-01-04 | ||||
| Johnson & Johnson | Mebendazole | Vermox | 1982-01-01 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
50%1/2
Phase 3
100%7/7
Approved: 6Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use